China ENG(Endoglin precursor) Market Research Report 2018

February 2018 | 121 pages | ID: C223434A69DQEN
QYResearch

Abstracts

The global ENG(Endoglin precursor) market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the ENG(Endoglin precursor) development status and future trend in China, focuses on top players in China, also splits ENG(Endoglin precursor) by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Aviva Systems Biology Corporation(USA)
• Atlas Antibodies(Sweden)
• Abbexa Ltd(UK)
• Abiocode(US)
• Boster Biological Technology(USA)
• Biobyt(UK)
• Bio-Rad(US)
• Bioss Antibodies(US)
• Biosensis(US)
• BioLegend(US)
• BioVision(US)
• BethylLaboratories(US)
• Epigentek(US)
• EnzoLifeSciences(Switzerland)
• Genetex(US)
• Lifespan Biosciences(US)
• Novus Biologicals(US)
• Proteintech(US)
• ProSci(US)
• ProteoGenix(France)
• R&D Systems(US)
• Rockland(US)
• St John's Laboratory Ltd(UK)
• Stemcell(Canada)
• Thermo Fisher Scientific(US)
• USBiological(US)

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Above 90%
• Above 95%
• Above 99%
• Others

On the basis of the end users/application, this report covers

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China ENG(Endoglin precursor) Market Research Report 2017

1 ENG(ENDOGLIN PRECURSOR) OVERVIEW

1.1 Product Overview and Scope of ENG(Endoglin precursor)
1.2 Classification of ENG(Endoglin precursor) by Product Category
  1.2.1 China ENG(Endoglin precursor) Sales (MT) Comparison by Type (2012-2022)
  1.2.2 China ENG(Endoglin precursor) Sales (MT) Market Share by Type in 2016
  1.2.3 Above 90%
  1.2.4 Above 95%
  1.2.5 Above 99%
  1.2.6 Others
1.3 China ENG(Endoglin precursor) Market by Application/End Users
  1.3.1 China ENG(Endoglin precursor) Sales (MT) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Biopharmaceutical Companies
  1.3.3 Hospitals
  1.3.4 Bioscience Research Institutions
  1.3.5 Others
1.4 China ENG(Endoglin precursor) Market by Region
  1.4.1 China ENG(Endoglin precursor) Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China ENG(Endoglin precursor) Status and Prospect (2012-2022)
  1.4.3 East China ENG(Endoglin precursor) Status and Prospect (2012-2022)
  1.4.4 Southwest China ENG(Endoglin precursor) Status and Prospect (2012-2022)
  1.4.5 Northeast China ENG(Endoglin precursor) Status and Prospect (2012-2022)
  1.4.6 North China ENG(Endoglin precursor) Status and Prospect (2012-2022)
  1.4.7 Central China ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of ENG(Endoglin precursor) (2012-2022)
  1.5.1 China ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2022)
  1.5.2 China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA ENG(ENDOGLIN PRECURSOR) MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China ENG(Endoglin precursor) Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China ENG(Endoglin precursor) Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China ENG(Endoglin precursor) Average Price (USD/Kg) by Players/Manufacturers (2012-2017)
2.4 China ENG(Endoglin precursor) Market Competitive Situation and Trends
  2.4.1 China ENG(Endoglin precursor) Market Concentration Rate
  2.4.2 China ENG(Endoglin precursor) Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers ENG(Endoglin precursor) Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA ENG(ENDOGLIN PRECURSOR) SALES AND REVENUE BY REGION (2012-2017)

3.1 China ENG(Endoglin precursor) Sales (MT) and Market Share by Region (2012-2017)
3.2 China ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China ENG(Endoglin precursor) Price (USD/Kg) by Regions (2012-2017)

4 CHINA ENG(ENDOGLIN PRECURSOR) SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China ENG(Endoglin precursor) Sales (MT) and Market Share by Type/ Product Category (2012-2017)
4.2 China ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China ENG(Endoglin precursor) Price (USD/Kg) by Type (2012-2017)
4.4 China ENG(Endoglin precursor) Sales Growth Rate (%) by Type (2012-2017)

5 CHINA ENG(ENDOGLIN PRECURSOR) SALES BY APPLICATION (2012-2017)

5.1 China ENG(Endoglin precursor) Sales (MT) and Market Share by Application (2012-2017)
5.2 China ENG(Endoglin precursor) Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA ENG(ENDOGLIN PRECURSOR) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aviva Systems Biology Corporation(USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Atlas Antibodies(Sweden)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abbexa Ltd(UK)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abbexa Ltd(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abiocode(US)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abiocode(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Boster Biological Technology(USA)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Boster Biological Technology(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biobyt(UK)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biobyt(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Rad(US)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Rad(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bioss Antibodies(US)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bioss Antibodies(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biosensis(US)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biosensis(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BioLegend(US)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 ENG(Endoglin precursor) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BioLegend(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BioVision(US)
6.12 BethylLaboratories(US)
6.13 Epigentek(US)
6.14 EnzoLifeSciences(Switzerland)
6.15 Genetex(US)
6.16 Lifespan Biosciences(US)
6.17 Novus Biologicals(US)
6.18 Proteintech(US)
6.19 ProSci(US)
6.20 ProteoGenix(France)
6.21 R&D Systems(US)
6.22 Rockland(US)
6.23 St John's Laboratory Ltd(UK)
6.24 Stemcell(Canada)
6.25 Thermo Fisher Scientific(US)
6.26 USBiological(US)

7 ENG(ENDOGLIN PRECURSOR) MANUFACTURING COST ANALYSIS

7.1 ENG(Endoglin precursor) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of ENG(Endoglin precursor)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 ENG(Endoglin precursor) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of ENG(Endoglin precursor) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA ENG(ENDOGLIN PRECURSOR) MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China ENG(Endoglin precursor) Sales (MT), Revenue (Million USD) Forecast (2017-2022)
11.2 China ENG(Endoglin precursor) Sales (MT) Forecast by Type (2017-2022)
11.3 China ENG(Endoglin precursor) Sales (MT) Forecast by Application (2017-2022)
11.4 China ENG(Endoglin precursor) Sales (MT) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table ENG(Endoglin precursor) Sales (MT) and Revenue (Million USD) Market Split by Product Type
Table ENG(Endoglin precursor) Sales (MT) by Application (2016-2022)
Figure Product Picture of ENG(Endoglin precursor)
Table China ENG(Endoglin precursor) Sales (MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China ENG(Endoglin precursor) Sales Volume Market Share by Types in 2016
Figure Above 90% Product Picture
Figure Above 95% Product Picture
Figure Above 99% Product Picture
Figure Others Product Picture
Figure China ENG(Endoglin precursor) Sales (MT) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of ENG(Endoglin precursor) by Application in 2016
Figure Biopharmaceutical Companies Examples
Table Key Downstream Customer in Biopharmaceutical Companies
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Bioscience Research Institutions Examples
Table Key Downstream Customer in Bioscience Research Institutions
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure China ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2022)
Figure China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China ENG(Endoglin precursor) Sales of Key Players/Manufacturers (2012-2017)
Table China ENG(Endoglin precursor) Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China ENG(Endoglin precursor) Sales Share (%) by Players/Manufacturers
Figure 2017 China ENG(Endoglin precursor) Sales Share (%) by Players/Manufacturers
Table China ENG(Endoglin precursor) Revenue by Players/Manufacturers (2012-2017)
Table China ENG(Endoglin precursor) Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China ENG(Endoglin precursor) Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China ENG(Endoglin precursor) Revenue Market Share (%) by Players/Manufacturers
Table China Market ENG(Endoglin precursor) Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market ENG(Endoglin precursor) Average Price of Key Players/Manufacturers in 2016
Figure China ENG(Endoglin precursor) Market Share of Top 3 Players/Manufacturers
Figure China ENG(Endoglin precursor) Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers ENG(Endoglin precursor) Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers ENG(Endoglin precursor) Product Category
Table China ENG(Endoglin precursor) Sales (MT) by Regions (2012-2017)
Table China ENG(Endoglin precursor) Sales Share (%) by Regions (2012-2017)
Figure China ENG(Endoglin precursor) Sales Share (%) by Regions (2012-2017)
Figure China ENG(Endoglin precursor) Sales Market Share (%) by Regions in 2016
Table China ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China ENG(Endoglin precursor) Revenue Market Share (%) by Regions (2012-2017)
Figure China ENG(Endoglin precursor) Revenue Market Share (%) by Regions (2012-2017)
Figure China ENG(Endoglin precursor) Revenue Market Share (%) by Regions in 2016
Table China ENG(Endoglin precursor) Price (USD/Kg) by Regions (2012-2017)
Table China ENG(Endoglin precursor) Sales (MT) by Type (2012-2017)
Table China ENG(Endoglin precursor) Sales Share (%) by Type (2012-2017)
Figure China ENG(Endoglin precursor) Sales Share (%) by Type (2012-2017)
Figure China ENG(Endoglin precursor) Sales Market Share (%) by Type in 2016
Table China ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Type (2012-2017)
Table China ENG(Endoglin precursor) Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of ENG(Endoglin precursor) by Type (2012-2017)
Figure Revenue Market Share of ENG(Endoglin precursor) by Type in 2016
Table China ENG(Endoglin precursor) Price (USD/Kg) by Types (2012-2017)
Figure China ENG(Endoglin precursor) Sales Growth Rate (%) by Type (2012-2017)
Table China ENG(Endoglin precursor) Sales (MT) by Applications (2012-2017)
Table China ENG(Endoglin precursor) Sales Market Share (%) by Applications (2012-2017)
Figure China ENG(Endoglin precursor) Sales Market Share (%) by Application (2012-2017)
Figure China ENG(Endoglin precursor) Sales Market Share (%) by Application in 2016
Table China ENG(Endoglin precursor) Sales Growth Rate (%) by Application (2012-2017)
Figure China ENG(Endoglin precursor) Sales Growth Rate (%) by Application (2012-2017)
Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Basic Information List
Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Basic Information List
Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Abbexa Ltd(UK) ENG(Endoglin precursor) Basic Information List
Table Abbexa Ltd(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Abiocode(US) ENG(Endoglin precursor) Basic Information List
Table Abiocode(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Abiocode(US) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Abiocode(US) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Abiocode(US) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Boster Biological Technology(USA) ENG(Endoglin precursor) Basic Information List
Table Boster Biological Technology(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Biobyt(UK) ENG(Endoglin precursor) Basic Information List
Table Biobyt(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Biobyt(UK) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Biobyt(UK) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Biobyt(UK) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Bio-Rad(US) ENG(Endoglin precursor) Basic Information List
Table Bio-Rad(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bio-Rad(US) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bio-Rad(US) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Bio-Rad(US) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Bioss Antibodies(US) ENG(Endoglin precursor) Basic Information List
Table Bioss Antibodies(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table Biosensis(US) ENG(Endoglin precursor) Basic Information List
Table Biosensis(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Biosensis(US) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure Biosensis(US) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure Biosensis(US) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table BioLegend(US) ENG(Endoglin precursor) Basic Information List
Table BioLegend(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure BioLegend(US) ENG(Endoglin precursor) Sales (MT) and Growth Rate (%)(2012-2017)
Figure BioLegend(US) ENG(Endoglin precursor) Sales Market Share (%) in China (2012-2017)
Figure BioLegend(US) ENG(Endoglin precursor) Revenue Market Share (%) in China (2012-2017)
Table BioVision(US) ENG(Endoglin precursor) Basic Information List
Table BethylLaboratories(US) ENG(Endoglin precursor) Basic Information List
Table Epigentek(US) ENG(Endoglin precursor) Basic Information List
Table EnzoLifeSciences(Switzerland) ENG(Endoglin precursor) Basic Information List
Table Genetex(US) ENG(Endoglin precursor) Basic Information List
Table Lifespan Biosciences(US) ENG(Endoglin precursor) Basic Information List
Table Novus Biologicals(US) ENG(Endoglin precursor) Basic Information List
Table Proteintech(US) ENG(Endoglin precursor) Basic Information List
Table ProSci(US) ENG(Endoglin precursor) Basic Information List
Table ProteoGenix(France) ENG(Endoglin precursor) Basic Information List
Table R&D Systems(US) ENG(Endoglin precursor) Basic Information List
Table Rockland(US) ENG(Endoglin precursor) Basic Information List
Table St John's Laboratory Ltd(UK) ENG(Endoglin precursor) Basic Information List
Table Stemcell(Canada) ENG(Endoglin precursor) Basic Information List
Table Thermo Fisher Scientific(US) ENG(Endoglin precursor) Basic Information List
Table USBiological(US) ENG(Endoglin precursor) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ENG(Endoglin precursor)
Figure Manufacturing Process Analysis of ENG(Endoglin precursor)
Figure ENG(Endoglin precursor) Industrial Chain Analysis
Table Raw Materials Sources of ENG(Endoglin precursor) Major Players/Manufacturers in 2016
Table Major Buyers of ENG(Endoglin precursor)
Table Distributors/Traders List
Figure China ENG(Endoglin precursor) Sales (MT) and Growth Rate (%) Forecast (2017-2022)
Figure China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China ENG(Endoglin precursor) Price (USD/Kg) Trend Forecast (2017-2022)
Table China ENG(Endoglin precursor) Sales (MT) Forecast by Type (2017-2022)
Figure China ENG(Endoglin precursor) Sales (MT) Forecast by Type (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume Market Share Forecast by Type in 2022
Table China ENG(Endoglin precursor) Sales (MT) Forecast by Application (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume Market Share Forecast by Application (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume Market Share Forecast by Application in 2022
Table China ENG(Endoglin precursor) Sales (MT) Forecast by Regions (2017-2022)
Table China ENG(Endoglin precursor) Sales Volume Share Forecast by Regions (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume Share Forecast by Regions (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources